MVV234K Law and Health Technology

Faculty of Law
Autumn 2017
Extent and Intensity
0/1/0. 5 credit(s). Type of Completion: k (colloquium).
Teacher(s)
Prof. Samuel D. Bernal (lecturer), doc. JUDr. Ing. Michal Radvan, Ph.D. (deputy)
Guaranteed by
doc. JUDr. Ing. Michal Radvan, Ph.D.
Faculty of Law
Contact Person: Mgr. Věra Redrupová, B.A.
Supplier department: Faculty of Law
Timetable of Seminar Groups
MVV234K/01: Mon 25. 9. 16:40–18:10 025, Tue 26. 9. 8:00–9:30 025, 9:35–11:05 025, 16:40–18:10 025, Wed 27. 9. 16:40–18:10 025, Mon 2. 10. 8:00–9:30 025, 9:35–11:05 025, Fri 6. 10. 8:00–9:30 302
Course Enrolment Limitations
The course is only offered to the students of the study fields the course is directly associated with.

The capacity limit for the course is 30 student(s).
Current registration and enrolment status: enrolled: 0/30, only registered: 0/30
fields of study / plans the course is directly associated with
there are 37 fields of study the course is directly associated with, display
Course objectives
At the end of the course students should be able to:
1.gain insights into the legal implications of recent advances in health technologies ... ;
2.develop an understanding of the legal basis of regulations in genetic, molecular and cellular technologies applied to health ... ;
3.create a framework to understand the legal basis for litigation in new health technologies ... ;
4.make reasoned decisions about approaches in providing legal advice to commercial companies, non-profit organizations, academic institutions and governmental agencies on new health technologies ... ;
5.make deductions based on acquired knowledge about the various factors that influence legal issues and decisions on regulations and litigation involving new health technologies... ;
6.interpret the scientific and technological information in the context of the legal framework for the applications of new health technologies... .
Syllabus
  • I. Law and New Health Technologies:
  • A. Genetic Sequencing
  • 1. In guiding diagnosis, prognostication and treatment of patients with cancer
  • 2. In guiding diagnosis, prognostication and treatment of patients with degenerative diseases
  • 3. In assessing genetic risk of development of cancer and degenerative diseases
  • 4. In tracing genetic basis on inherited diseases
  • B. Gene Therapy
  • C. Molecular Tests
  • D. Molecular Therapies
  • E. Cellular Tests
  • F. Cellular Therapies and Stem Cells
  • II. Law of Privacy and Patient Information
  • III. Law, Information Technology and Health
  • IV. Law, Telemedicine and Mobile Health Technologies – Regulation and Liability
  • V. Patents and their influence on regulation, commercialization and litigation in new health technologies
  • A. Patenting gene sequences
  • B. Patenting genetic technologies
  • C. Patenting living cells and cellular technologies
Literature
  • See Teacher’s Information for full details.
Teaching methods
lectures, discussions
Assessment methods
Term Paper and Essay Exam
Language of instruction
English
Further comments (probably available only in Czech)
The course is taught only once.
  • Enrolment Statistics (recent)
  • Permalink: https://is.muni.cz/course/law/autumn2017/MVV234K